1. Home
  2. Analysis
  3. Embolism-venous
  4. C-reactive-protein-increased

Embolism venous and C-reactive protein increased

Summary:

C-reactive protein increased is found among people with Embolism venous, especially for people who are female, 60+ old.

The study analyzes which people have C-reactive protein increased with Embolism venous. It is created by eHealthMe based on reports of 59 people who have Embolism venous from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Embolism venous?

Embolism venous (embolus may pass into the arterial system) is found to be associated with 308 drugs and 393 conditions by eHealthMe. Check the latest studies of Embolism venous.

What is C-reactive protein increased?

C-reactive protein increased is found to be associated with 1,568 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.

On Jul, 26, 2026

59 people who have Embolism Venous and C-Reactive Protein Increased are studied.

Would you have C-reactive protein increased when you have Embolism venous?

Gender of people who have Embolism Venous and experienced C-Reactive Protein Increased *:

  • female: 94.55 %
  • male: 5.45 %

Age of people who have Embolism Venous and experienced C-Reactive Protein Increased *:

  • 0-1: 1.82 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.82 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 1.82 %
  • 60+: 94.55 %

Common co-existing conditions for these people *:

  1. Breast Cancer Metastatic: 48 people, 81.36%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 16.95%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 3.39%
  4. Pain: 2 people, 3.39%
  5. Nausea (feeling of having an urge to vomit): 2 people, 3.39%
  6. Hyperglycemia (high blood sugar): 1 person, 1.69%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.69%
  8. Constipation: 1 person, 1.69%
  9. Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 1 person, 1.69%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 1.69%

Common drugs taken by these people *:

  1. Paclitaxel: 29 people, 49.15%
  2. Capecitabine: 29 people, 49.15%
  3. Exemestane: 29 people, 49.15%
  4. Omeprazole: 29 people, 49.15%
  5. Fluorouracil: 10 people, 16.95%
  6. Carboplatin: 10 people, 16.95%
  7. Cyclophosphamide: 10 people, 16.95%
  8. Gemcitabine: 8 people, 13.56%
  9. Soltamox: 8 people, 13.56%
  10. Eribulin Mesylate: 8 people, 13.56%

Common symptoms for these people *:

  1. Ascites (accumulation of fluid in the abdominal cavity): 51 people, 86.44%
  2. Urinary Tract Infection: 51 people, 86.44%
  3. Blood Alkaline Phosphatase Increased: 51 people, 86.44%
  4. Fever: 51 people, 86.44%
  5. Blood Urea Increased: 51 people, 86.44%
  6. White Blood Cell Count Increased: 50 people, 84.75%
  7. Nausea (feeling of having an urge to vomit): 50 people, 84.75%
  8. Alanine Aminotransferase Increased: 50 people, 84.75%
  9. Aspartate Aminotransferase Increased: 50 people, 84.75%
  10. Nausea And Vomiting: 50 people, 84.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have C-reactive protein increased?

- Check whether C-reactive protein increased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with C-reactive protein increased:

All the conditions that are associated with C-reactive protein increased:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on C-reactive protein increased and Embolism venous, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.